NCT02593539 Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI Status COMPLETED Phase PHASE2
NCT02588612 Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT02588326 Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays Status COMPLETED Phase PHASE1
NCT02586506 Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma Status COMPLETED Phase PHASE4
NCT02586493 Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects Status COMPLETED Phase PHASE4
NCT02581410 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier Status COMPLETED Phase PHASE3
NCT02578953 Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects Status COMPLETED Phase PHASE1
NCT02576119 A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects Status TERMINATED Phase PHASE1
NCT02573870 Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT02570165 Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02570152 A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia Status COMPLETED Phase NA
NCT02570126 A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. Status COMPLETED Phase PHASE3
NCT02569879 Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia. Status COMPLETED Phase N/A
NCT02568592 Exercise Substrate Utilisation and Endurance Performance Following Short-term Manipulation of Dietary Fat Intake Status UNKNOWN Phase NA
NCT02568332 A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals Status COMPLETED Phase PHASE1
NCT02567773 Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078 Status COMPLETED Phase PHASE1
NCT02567747 Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age Status COMPLETED Phase N/A
NCT02567721 Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK) Status COMPLETED Phase N/A
NCT02567708 A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma Status COMPLETED Phase PHASE2
NCT02564055 A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2